IMD-2560

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIMD-2560
Drug Alias NameIMD-2560
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibitor of NF-kappa-B kinase (IKK) inhibitors
TargetsInhibitor of NF-kappa-B kinase (IKK)
Therapy Area/IndicationsOsteoarthritisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Medicinal Molecular Design Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitute Of Medicinal Molecular Design Inc
Active IndicationsN/A
Inactive IndicationsOsteoarthritisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A